VS

Vidyarani Subhash Dasari

Active Director Additional Director DIN 10998813
DIN 10998813 First appointment Mar 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Vidyarani Subhash Dasari

Data last updated:

Vidyarani Subhash Dasari is an Additional Director at Rajvir Pharma Private Limited (since 2025). The company operates in Pharma.

DIN 10998813
Primary Designation Additional Director
Industry Pharma
First Appointment 13 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rajvir Pharma Private Limited U46497MH2024PTC434925
Additional Director13 Mar 20252024Active

Board colleagues of Vidyarani Subhash Dasari

NameDINCompanyDesignation
Subhash Jagannatham Dasari10998869Rajvir Pharma Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Rajvir Pharma Private Limited
Premium access

Shareholding and investment profile for Vidyarani Subhash Dasari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vidyarani Subhash Dasari

Vidyarani Subhash Dasari currently holds 1 directorship: Rajvir Pharma Private Limited (Additional Director, since 13 Mar 2025).

Vidyarani Subhash Dasari was first appointed on 13 Mar 2025 as Additional Director at Rajvir Pharma Private Limited.

The current boards of Vidyarani Subhash Dasari's companies include Subhash Jagannatham Dasari (Rajvir Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available